Zurueck zur Suche

Reporte zur Charge UT8076MA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 2 VA 1 PA 1 CT 1 IN 1

VAERS 2699750

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076MA

schwer
Staat
NY
Alter
15,0
Geschlecht
F
Eingang
21.10.2023
Impfdatum
21.10.2023
Beginn
21.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Syncope

Symptomtext

Fainting event immediately after administration. Patient recovered in under a minute and did not fall at any point. She was seated the whole time and me and the parents were able to keep her up right. Patient was given water and offerd snacks. She was well within about 10 minutes and was monitroed for for approximately 45 minutes post vaccination. Patient attributed episode to nervousness about getting vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2698525

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut8076ma

schwer
Staat
VA
Alter
14,0
Geschlecht
F
Eingang
19.10.2023
Impfdatum
19.10.2023
Beginn
19.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Within 2 minutes of administration, patient fainted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2722959

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076MA

moderat
Staat
-
Alter
57,0
Geschlecht
F
Eingang
11.12.2023
Impfdatum
03.12.2023
Beginn
03.12.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal discomfort Back pain Frequent bowel movements Headache Jaundice Malaise Paraesthesia

Symptomtext

frequent evacuation; gastrointestinal upset; back pain; jaundice; prickling in finger tips, hands and heels; significant malaise; within 18 hours headache began; Initial information was received on 05-Dec-2023 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (Patient). This case involves a 57 years old female patient who experienced within 18 hours headache began, frequent evacuation, significant malaise, gastrointestinal upset, back pain, jaundice and prickling in finger tips, hands and heels after receiving INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had no medical history, concomitant disease or risk factor. On 03-Dec-2023, the patient received a unknown dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (Suspension for injection) (lot UT8076MA,strength, expiry date was unknown) via intramuscular route in unknown administration site for prophylactic vaccination(Immunization). On 03-DEC-2023 the patient developed within 18 hours headache began (headache), frequent evacuation (frequent bowel movements), significant malaise (malaise) , gastrointestinal upset (abdominal discomfort), back pain, jaundice and prickling in finger tips, hands and heels (paraesthesia) (latency : same day) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the events (within 18 hours headache began, frequent evacuation, significant malaise, gastrointestinal upset, back pain, jaundice, prickling in finger tips, hands and heels). At time of reporting, the outcome was Recovering / Resolving for all the events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2714987

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076MA

moderat
Staat
PA
Alter
60,0
Geschlecht
M
Eingang
17.11.2023
Impfdatum
27.09.2023
Beginn
28.09.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Atrial fibrillation Dizziness Echocardiogram Electrocardiogram abnormal Heart rate decreased Palpitations Sinus rhythm Troponin I

Symptomtext

Heart palpitations and some lightheadedness. Diagnosed as Atrial Fibrillation following ECG in cardiologist's office. Confirmed in Hospital ER. Admitted to Hospital for treatment. Returned to normal sinus rhythm following 13 hours treatment with medicines to lower heart rate. Discharged home the following day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
2,0
Labordaten
ECG, Troponin I, Echocardiogram. All conducted on 9/28/23 at Hospital.
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension, GERD
Andere Medikamente
Fexofenadine, Metoprolol, Losartan, Melatonin, Ambien
Allergien
Seasonal allergies
Vorherige Impfungen
-

VAERS 2692476

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076MA

moderat
Staat
NY
Alter
57,0
Geschlecht
F
Eingang
07.10.2023
Impfdatum
07.10.2023
Beginn
07.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chest discomfort Cough Dyspnoea Wheezing

Symptomtext

Approximately 5 hours after receiving the injections I experienced shortness of breath, coughing, wheezing, chest tightness. I took a claritin with relief immediately. I received two doses of the COVID vaccine (Pfizer) originally, did not receive a third shot (I had covid) and had no prior reaction I have received the flu vaccine in the past without incident as well Earlier in the day, prior to the vaccine, I noticed some tightness / shortness of breath-- but the response was significantly worse at 9PM. This reaction may be a reaction to in-home air fresheners (there is significant aroma and I am sensitive, although never "allergic" I will follow up with my primary care provider on Monday

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Airborne Immunity with Elderberry
Allergien
Possible allergy to NSAID
Vorherige Impfungen
-

VAERS 2700155

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076MA

gering
Staat
CT
Alter
60,0
Geschlecht
F
Eingang
23.10.2023
Impfdatum
18.10.2023
Beginn
18.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blepharitis Blister Skin discolouration Swelling of eyelid

Symptomtext

Developed blepharitis in both eyes, but particularly evident in right eye, which blistered along edge of eyelid and turned dark purple. Reaction started within 2 hours after vaccine was administered, became most intense within 24 hours, and started to recede after 48 hours. Treated with increased prednisolone eye drops (3 times a day instead of once a day), topical triamcinolone, advil (oral), and hot compresses. Five days later there is still some swelling of both eyelids, but condition is much improved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blepharitis
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Tested positive (home test) for Covid just over 5 weeks earlier.
Vorgeschichte
Open angle glaucoma
Andere Medikamente
Prednisolone ophthalmic drops
Allergien
Lumigan (bimatoprost); dorzolamide; cold urticaria; sesame; mustard; bee stings; feathers, various grasses/trees
Vorherige Impfungen
Very reactive to Moderna COVID vaccine at age 59-60 with aches, fever, chills (full series plus booster)

VAERS 2693209

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8076MA

gering
Staat
IN
Alter
75,0
Geschlecht
M
Eingang
10.10.2023
Impfdatum
02.10.2023
Beginn
02.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

inadvertently administered Fluzone QIV Np instead of the intended Fluzone High Dose QIV to a patient who is over 65 years old with no reported adverse event; Initial information received on 02-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 75 years old male patient who was inadvertently administered fluzone qiv np instead of the intended fluzone high dose qiv to a patient who is over 65 years old with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Oct-2023, the patient received 0.5 ml dose of suspect influenza quadrival A-B vaccine, Suspension for injection lot UT8076MA via unknown route in the left deltoid for immunization (strength, expiry date: unknown), inadvertently administered fluzone qiv np instead of the intended fluzone high dose qiv to a patient who is over 65 years old with no reported adverse event (wrong product administered) (latency same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event wrong product administered This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-